Physician profile
Mila Ioussifova
NPI 1821282609
$222,926.65
in general payments reported to CMS, 2019-2025
25 companies · $91K in 2025
The $91K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,767 · 2020: $2,387 · 2021: $405 · 2022: $7,128 · 2023: $42K · 2024: $78K · 2025: $91K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $77K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $53K · Travel and Lodging: $35K · Food and Beverage: $23K · Consulting Fee: $22K · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $77,325.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $53,440.00 |
| Travel and Lodging | $35,473.29 |
| Food and Beverage | $23,039.59 |
| Consulting Fee | $21,925.00 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $72,900.75 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $62,926.40 | 2019-2025 | Cequa, Bromsite, Xelpros |
| Bausch & Lomb Americas INC. | $51,402.32 | 2022-2025 | Miebo, Xiidra, Blink Nutritears |
| Lumenis Be INC | $14,193.00 | 2022-2025 | Optilight |
| Biotissue Holdings INC. | $8,025.25 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $5,603.52 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $3,186.11 | 2022-2024 | Tearcare System |
| Abbvie INC. | $2,119.77 | 2022-2025 | |
| Alcon Vision LLC | $609.07 | 2019-2025 | Tryptyr, Eysuvis |
| Oyster Point Pharma, INC. | $515.06 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Dompe US, INC. | $466.20 | 2021-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $227.09 | 2019-2024 | Lipiflow System Activator (Disposable) |
| Mallinckrodt Hospital Products INC. | $223.81 | 2024-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $91.08 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $77.44 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Walman Optical Company | $66.50 | 2019-2022 | |
| Harrow Eye, LLC | $60.94 | 2024 | |
| Shire North American Group INC | $58.67 | 2019 | |
| Horizon Therapeutics Plc | $50.04 | 2022-2023 | Tepezza |
| Ani Pharmaceuticals, INC. | $42.48 | 2025 | Purified Cortrophin Gel |
| Revance Therapeutics, INC. | $27.84 | 2025 | Daxxify |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Allergan, INC. | $12.80 | 2021 | |
| Tearlab Corp | $11.73 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mila Ioussifova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.